Shoulder Innovations, Inc.SI

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$17.01
Market cap
$354.1M
P/E
—
Revenue (TTM)
$60.1M
Net income
-$35.0M
Dividend yield
—
1-year total return
36.1%
Net margin
-58.3%
Revenue growth
60.9%
Debt / equity
0.12x

What Shoulder Innovations, Inc. does.

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Our ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care. We believe our exclusive focus on shoulder surgical care, combined with a highly specialized commercial organization and strong clinical data, positions us well to capture significant share in this large, growing market.

Shoulder pain is highly prevalent, often chronic, and can significantly reduce quality of life. The primary conditions that can result in shoulder pain and reduced functionality include osteoarthritis, rheumatoid arthritis, rotator cuff tears and shoulder fractures. These shoulder conditions are widespread, often debilitating, and are commonly experienced concurrently as interrelated musculoskeletal disorders. According to data from the National Institutes of Health, we estimate that these conditions result in more than eight million physician visits annually in the United States. Despite this prevalence, we believe there has been a historical underutilization of surgical treatments for shoulder care due to several factors including patient hesitation to pursue surgical intervention, insufficient technology to appropriately treat shoulder conditions, complex shoulder anatomy, perceived difficulty of surgical intervention and barriers to patient access of care.

Revenue and profit, by fiscal year.

Fiscal year202320242025
Revenue—$31.6M$47.3M
Net income—-$15.6M-$40.4M
Free cash flow—-$18.2M-$36.0M

More on SI.

Figures from Shoulder Innovations, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.